Prevalences of acute/chronic HBV-infection, occult HBV-infection, cleared HBV-infection and HBV-vaccination in MSM with known date of HIV 1-seroconversion, by age at HIV 1-seroconversion (for comparisons: Fisher’s exact test)
| Acute/chronic HBV: Anti-HBc (+), Anti-HBs (-), HBs-AG (+) | p | occult HBV: Anti-HBc (+), Anti-HBs (-), HBs-AG (-) | p | cleared HBV: Anti-HBc (+), Anti-HBs (+), HBs-AG (-) | p | HBV-vaccination: Anti-HBc (-), Anti-HBs (+), HBs-AG (-) | p | |
|---|---|---|---|---|---|---|---|---|
| Age groups | .311 | .053 | < 0.001 | < 0.001 | ||||
| < 25 years (n = 256) | 0.4% | 3.5% | 14.1% | 62.9% | ||||
| 25–34 years (n = 843) | 2.3% | 4.0% | 23.0% | 51.6% | ||||
| 35–44 years (n = 595) | 2.2% | 6.7% | 34.6% | 43.9% | ||||
| 45–54 years (n = 163) | 1.2% | 3.1% | 47.2% | 33.1% | ||||
| ≥ 55 years (n = 32) | 0% | 9.4% | 50.0% | 21.9% | ||||